# Continuous Wound Infiltration After Hallux Valgus Surgery

> **NCT02182999** · PHASE4 · COMPLETED · sponsor: **Medical University Innsbruck** · enrollment: 50 (actual)

## Conditions studied

- Hallux Valgus

## Interventions

- **DEVICE:** Wound infiltration catheter
- **DRUG:** NaCl 0.9%
- **DRUG:** Ropivacaine 0.2%

## Key facts

- **NCT ID:** NCT02182999
- **Lead sponsor:** Medical University Innsbruck
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2017-04
- **Final completion:** 2017-04
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2018-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02182999

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02182999, "Continuous Wound Infiltration After Hallux Valgus Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02182999. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*